BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
News | 02. 08. 2012
Scott Weiner will present and sit on a panel at the IN3 Medical Device 360 conference on February 29th through March 2nd in Orlando, Florida.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.